IP Library Granted Patent US 7,220,775
Granted Patent B2
US 7,220,775 · App. 10/637,299 · Granted May 22, 2007

Compound useful for the treatment of neuropathic pain

Assignee: H. Lundbeck A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,775
App. No.
10/637,299
Granted
May 22, 2007
Kind
B2
Abstract

This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor and are useful for the treatment of neuropathic pain and other abnormalities. This invention also provides a method of treating a subject suffering from an abnormality which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's abnormality. This invention also provides a method of treating an abnormality in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.

Claims (2)

1. A method of treating a subject suffering from neuropathic pain, which comprises administering to the subject an amount of a compound effective to treat the subject's neuropathic pain, wherein the compound has the structure:

or a pharmaceutically acceptable salt thereof

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2012
From: DART NEUROSCIENCE LLC
To: DART NEUROSCIENCE (CAYMAN) LTD.
Reel/Frame 029361/0977 →
MERGER Recorded Nov 8, 2012
From: HELICON THERAPEUTICS, INC.
To: DART NEUROSCIENCE LLC
Reel/Frame 029293/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2004
From: SYNAPTIC PHARMACEUTICAL CORPORATION
To: H. LUNDBECK A/S
Reel/Frame 015156/0196 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2004
From: BLACKBURN, THOMAS P.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 014916/0689 →
Continuity (2)
Provisional Application 6040203500 · Aug 7, 2002
Related Publication 20040092570A1 · May 13, 2004